Navigation Links
Amikacin Inhale Shows Promising Results in Phase II Study
Date:5/19/2008

cin Lung Deposition Correlates with in vitro Findings(5)

This study describes the in-vitro and in-vivo characterization of a handheld version of Amikacin Inhale, intended for use in extubated patients. In-vitro, amikacin 400 mg was aerosolized continuously, and emitted mass captured on absolute filters distal to the mouthpiece during simulated adult tidal breathing. Emitted mass was 87 percent of the 400 mg amikacin nominal dose, with a predicted lung dose of 45-50 percent. In-vivo, Amikacin Inhale (400 mg amikacin) labeled with 99mTc was administered to healthy subjects using the hand-held version. In these, mean amikacin lung dose determined via scintigraphy was 172.2 mg, 43 percent of the nominal dose. These results show that the hand-held drug-device combination delivered a large fraction of the starting dose, confirming the high delivery efficiency predicted by in-vitro aerosol characterization. The study also confirmed that the in-vitro model is predictive of the in-vivo experience. Lung doses in the range of those observed are expected to achieve bacteriological eradiation.

Copies of abstracts are available and can be viewed online at the ATS website: http://www.abstracts2view.com/ats08/

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing an
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
2. Inhaled Steriods Used as Preventive Treatment Post 9/11
3. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
4. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
8. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DALLAS , Apr. 17, 2015 Steven ... ( ALGA ), and its operating subsidiary American Seed ... an exclusive presentation to investors yesterday in New York ... Strategy. The American Seed & Oil Company ... , Hippie Butter Hemp Seed Foods , the ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research ... announced the addition of the "The Corporate ... 2014 - Global Edition " report to ... Pharmafrom a Patient Perspective, is now in its ... (2014 results; published early 2015). For each annual ...
Breaking Medicine Technology:American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... , BOZEMAN, Mont., Sept 8 LigoCyte Pharmaceuticals, ... human clinical trial of its norovirus vaccine. The Phase ... investigational, nasally-delivered, dry powder vaccine in healthy adults. The study ... infection by including a live virus challenge of subjects that ...
... , SEATTLE, Sept. 5 ... that the U.S. Food and Drug Administration (FDA) has notified ... date of April 23, 2010 under standard review has been ... relapsed or refractory aggressive non-Hodgkin,s lymphoma (NHL). Pixantrone has fast ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA 2FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA 3
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Riviera ... Dr. Kevin Sadati of the Gallery of Cosmetic ... County’s top beauty experts. The publication focused on ... facial stem cell fat grafting, eyelid surgery, laser resurfacing ... facial plastic surgery has resulted in thousands of ...
(Date:4/17/2015)... Tampa, Florida (PRWEB) April 17, 2015 ... Term Acute Care and Florida Hospital Carrollwood were all ... Hospital Wesley Chapel, located in Pasco County, is ranked ... Bay Times workplaces survey, which was conducted in partnership ... is an 83 all-private bed hospital that opened in ...
(Date:4/17/2015)... April 17, 2015 From the day Dr. ... the Texas non-profit organization has empowered young people to create ... to bring fresh water and the Gospel to all ... University. Between March 17 and 27, students, faculty and staff ... Liberians with fresh water and the Good News of Jesus. ...
(Date:4/17/2015)... CA (PRWEB) April 17, 2015 Consumers ... insurance protection without modifications can now use the Insurance ... general life insurance policy rates that are featured by ... The standard plans that are offered are mixed between ... aged 18 to 79. There are now term, universal ...
Breaking Medicine News(10 mins):Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2
... in mice led to premature ovarian failure, researchers report ... they have discovered a mechanism that prompts early menopause ... , PTEN -- a gene that,s known for suppressing ... the ovary from ripening too quickly. When researchers deleted ...
... The new product development,process is exceedingly complex. It ... hundreds of millions of dollars in capital resources.,Not ... so complex that no single person in the ... For this reason, benchmark partners emphasize the importance ...
... leaders will,convene in Arlington, Virginia, March 6-8, 2008 ... strategies for the treatment of,common malignancies. State-of-the-art technology ... The Summit will provide 13.75 CME credits ... Foundation, and the content is being,developed under the ...
... Feb. 1, two,giant heart-shaped light displays will light up ... and remind women to take,care of their hearts all ... displays will adorn both,the north and south sides of ... downtown Detroit. The large red hearts show support,for American ...
... an infection caused by Onchocerca volvulus, a parasite nematode ... fly of the Simulium genus whose larvae develop in ... skin lesions but also eye damage that can lead ... blindness. A huge majorityy -- 99% -- of the ...
... hospitals already stocked with simple, inexpensive solution , , THURSDAY, Jan. ... sulfate) given just before delivery to pregnant women at high ... among these newborns in half, U.S. researchers report. , The ... States. All the women were at high risk for giving ...
Cached Medicine News:Health News:Study Spots Gene That Plays Role in Infertility 2Health News:Pharma Product Commercialization: Standardized Team Processes Help Save Complex Drug Launches 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3Health News:Heart-Shaped Light Displays on Blue Cross Blue Shield of Michigan Building Show Support for American Heart Month, National Wear Red Day 2Health News:The onchocerciasis parasite showing signs of resistance 2Health News:The onchocerciasis parasite showing signs of resistance 3Health News:Epsom Salt Cut Cerebral Palsy Rate in Half Among Preemies 2
... tradition of the USA Series, ACMITM introduces ... Elite System II -- the longest cystourethroscope ... Elite System offers the components you need ... USA Elite System II Cystourethroscopes provide all ...
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Inquire...
... Surgical MicroChoice® system is a set ... be operated using the Advantage®, PowerPro®, ... designed for use in the drilling, ... in a wide variety of procedures ...
Medicine Products: